Parmodia | Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Thai FDA Category Presentation/Packing

Full Prescribing Info

Adverse Reactions

Summary of the safety profile: In clinical studies conducted by the time of approval in Japan, adverse reactions were observed in 206 of 1,418 patients (14.5%). The most commonly reported adverse reactions included cholelithiasis observed in 20 patients (1.4%), diabetes mellitus in 20 patients (1.4%), and blood creatine phosphokinase increased in 12 patients (0.8%).
Summary of adverse reactions: Adverse reactions and frequencies observed in clinical studies conducted by the time of approval in Japan are listed as follows. If any of the following adverse reactions or similar is observed, the patients should be treated appropriately according to the symptoms. (See Table 15.)

Click on icon to see table/diagram/image

View ADR Reporting Link

Parmodia Adverse Reactions

Manufacturer:

Kowa

Distributor:

Biopharm

Marketer:

Kowa